XML 22 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Shares outstanding, beginning balance (in shares) at Dec. 31, 2020   540,714,692      
Shareholders' equity (deficit) beginning balance at Dec. 31, 2020 $ 1,553,000,000 $ 0 $ 2,596,000,000 $ (1,043,000,000) $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of stock (in shares)   32,817,421      
Issuance of stock 857,000,000   857,000,000    
Vesting of restricted stock (in shares)   1,370,447      
Issuance of common stock for settlement of RSUs, net of shares withheld for participant taxes (in shares)   24,004,565      
Conversion of common and preferred stock (in shares)   8,200,151      
Conversion of common and preferred stock 58,000,000   58,000,000    
Exercise of stock options (in shares)   8,919,289      
Exercise of stock options 15,000,000   15,000,000    
Purchases of Capped Calls related to the 2026 Notes (119,000,000)   (119,000,000)    
Stock-based compensation 548,000,000   548,000,000    
Other comprehensive (loss) income (2,000,000)       (2,000,000)
Net loss (662,000,000)     (662,000,000)  
Shares outstanding, ending balance (in shares) at Dec. 31, 2021   616,026,565      
Shareholders' equity (deficit) ending balance at Dec. 31, 2021 2,248,000,000 $ 0 3,955,000,000 (1,705,000,000) (2,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock (in shares)   628,193      
Issuance of common stock for settlement of RSUs, net of shares withheld for participant taxes (in shares)   17,279,891      
Exercise of stock options (in shares)   2,958,586      
Exercise of stock options 4,000,000   4,000,000    
Employee stock purchase plan (in shares)   493,790      
Issuance of common stock under employee stock purchase plan, net of shares withheld for participant taxes 2,000,000   2,000,000    
Stock-based compensation 187,000,000   187,000,000    
Other comprehensive (loss) income (2,000,000)       (2,000,000)
Net loss $ (1,353,000,000)     (1,353,000,000)  
Shares outstanding, ending balance (in shares) at Dec. 31, 2022 637,387,025 637,387,025      
Shareholders' equity (deficit) ending balance at Dec. 31, 2022 $ 1,086,000,000 $ 0 4,148,000,000 (3,058,000,000) (4,000,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for settlement of RSUs, net of shares withheld for participant taxes (in shares)   35,562,197      
Issuance of common stock for settlement of RSUs, net of shares withheld for participant taxes $ (1,000,000)   (1,000,000)    
Exercise of stock options (in shares) 2,535,000 2,535,147      
Exercise of stock options $ 3,000,000   3,000,000    
Employee stock purchase plan (in shares)   2,151,794      
Issuance of common stock under employee stock purchase plan, net of shares withheld for participant taxes 2,000,000   2,000,000    
Stock-based compensation 149,000,000   149,000,000    
Other comprehensive (loss) income 3,000,000       3,000,000
Net loss $ (275,000,000)     (275,000,000)  
Shares outstanding, ending balance (in shares) at Dec. 31, 2023 677,636,163 677,636,163      
Shareholders' equity (deficit) ending balance at Dec. 31, 2023 $ 967,000,000 $ 0 $ 4,301,000,000 $ (3,333,000,000) $ (1,000,000)